The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Nano-Drug Market Research Report 2025

Global Nano-Drug Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1905312

No of Pages : 112

Ask Your Query
Synopsis
The global Nano-Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Nano-Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Nano-Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Nano-Drug include Merck, Pfizer, Novartis, Abbott, GlaxoSmithKline, Roche, Sanofi, Eli Lilly and Astrazeneca, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Nano-Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nano-Drug.
Report Scope
The Nano-Drug market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nano-Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nano-Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Pfizer
Novartis
Abbott
GlaxoSmithKline
Roche
Sanofi
Eli Lilly
Astrazeneca
Johnson & Johnson
Celgene
Novavax
Stryker
Gilead Sciences
OSI Pharmaceuticals
Kadmon Pharmaceuticals
Samyang Biopharm
Mitsubishi Pharma
Kaken Pharmaceutical
Selecta Biosciences
Par Pharmaceutical
Cerulean Pharma
Navidea Biopharmaceuticals
Lummy
Segment by Type
Liposomes
Polymeric Micelles
Solid lipid Nanoparticles
Microemulsion and Nanoemulsion
Nanosuspension
Segment by Application
Cancer and Tumors
Autoimmune Disorders
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nano-Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nano-Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Nano-Drug Market Overview
1.1 Product Overview and Scope of Nano-Drug
1.2 Nano-Drug Segment by Type
1.2.1 Global Nano-Drug Market Value Comparison by Type (2024-2030)
1.2.2 Liposomes
1.2.3 Polymeric Micelles
1.2.4 Solid lipid Nanoparticles
1.2.5 Microemulsion and Nanoemulsion
1.2.6 Nanosuspension
1.3 Nano-Drug Segment by Application
1.3.1 Global Nano-Drug Market Value by Application: (2024-2030)
1.3.2 Cancer and Tumors
1.3.3 Autoimmune Disorders
1.4 Global Nano-Drug Market Size Estimates and Forecasts
1.4.1 Global Nano-Drug Revenue 2019-2030
1.4.2 Global Nano-Drug Sales 2019-2030
1.4.3 Global Nano-Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Nano-Drug Market Competition by Manufacturers
2.1 Global Nano-Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Nano-Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Nano-Drug Average Price by Manufacturers (2019-2024)
2.4 Global Nano-Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nano-Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nano-Drug, Product Type & Application
2.7 Nano-Drug Market Competitive Situation and Trends
2.7.1 Nano-Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nano-Drug Players Market Share by Revenue
2.7.3 Global Nano-Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nano-Drug Retrospective Market Scenario by Region
3.1 Global Nano-Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Nano-Drug Global Nano-Drug Sales by Region: 2019-2030
3.2.1 Global Nano-Drug Sales by Region: 2019-2024
3.2.2 Global Nano-Drug Sales by Region: 2025-2030
3.3 Global Nano-Drug Global Nano-Drug Revenue by Region: 2019-2030
3.3.1 Global Nano-Drug Revenue by Region: 2019-2024
3.3.2 Global Nano-Drug Revenue by Region: 2025-2030
3.4 North America Nano-Drug Market Facts & Figures by Country
3.4.1 North America Nano-Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Nano-Drug Sales by Country (2019-2030)
3.4.3 North America Nano-Drug Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Nano-Drug Market Facts & Figures by Country
3.5.1 Europe Nano-Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Nano-Drug Sales by Country (2019-2030)
3.5.3 Europe Nano-Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nano-Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Nano-Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Nano-Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Nano-Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Nano-Drug Market Facts & Figures by Country
3.7.1 Latin America Nano-Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Nano-Drug Sales by Country (2019-2030)
3.7.3 Latin America Nano-Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nano-Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Nano-Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Nano-Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Nano-Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Nano-Drug Sales by Type (2019-2030)
4.1.1 Global Nano-Drug Sales by Type (2019-2024)
4.1.2 Global Nano-Drug Sales by Type (2025-2030)
4.1.3 Global Nano-Drug Sales Market Share by Type (2019-2030)
4.2 Global Nano-Drug Revenue by Type (2019-2030)
4.2.1 Global Nano-Drug Revenue by Type (2019-2024)
4.2.2 Global Nano-Drug Revenue by Type (2025-2030)
4.2.3 Global Nano-Drug Revenue Market Share by Type (2019-2030)
4.3 Global Nano-Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Nano-Drug Sales by Application (2019-2030)
5.1.1 Global Nano-Drug Sales by Application (2019-2024)
5.1.2 Global Nano-Drug Sales by Application (2025-2030)
5.1.3 Global Nano-Drug Sales Market Share by Application (2019-2030)
5.2 Global Nano-Drug Revenue by Application (2019-2030)
5.2.1 Global Nano-Drug Revenue by Application (2019-2024)
5.2.2 Global Nano-Drug Revenue by Application (2025-2030)
5.2.3 Global Nano-Drug Revenue Market Share by Application (2019-2030)
5.3 Global Nano-Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Nano-Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Nano-Drug Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Nano-Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Nano-Drug Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Nano-Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis Nano-Drug Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Abbott
6.4.1 Abbott Corporation Information
6.4.2 Abbott Description and Business Overview
6.4.3 Abbott Nano-Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Abbott Nano-Drug Product Portfolio
6.4.5 Abbott Recent Developments/Updates
6.5 GlaxoSmithKline
6.5.1 GlaxoSmithKline Corporation Information
6.5.2 GlaxoSmithKline Description and Business Overview
6.5.3 GlaxoSmithKline Nano-Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 GlaxoSmithKline Nano-Drug Product Portfolio
6.5.5 GlaxoSmithKline Recent Developments/Updates
6.6 Roche
6.6.1 Roche Corporation Information
6.6.2 Roche Description and Business Overview
6.6.3 Roche Nano-Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Roche Nano-Drug Product Portfolio
6.6.5 Roche Recent Developments/Updates
6.7 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Nano-Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanofi Nano-Drug Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 Eli Lilly
6.8.1 Eli Lilly Corporation Information
6.8.2 Eli Lilly Description and Business Overview
6.8.3 Eli Lilly Nano-Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Eli Lilly Nano-Drug Product Portfolio
6.8.5 Eli Lilly Recent Developments/Updates
6.9 Astrazeneca
6.9.1 Astrazeneca Corporation Information
6.9.2 Astrazeneca Description and Business Overview
6.9.3 Astrazeneca Nano-Drug Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Astrazeneca Nano-Drug Product Portfolio
6.9.5 Astrazeneca Recent Developments/Updates
6.10 Johnson & Johnson
6.10.1 Johnson & Johnson Corporation Information
6.10.2 Johnson & Johnson Description and Business Overview
6.10.3 Johnson & Johnson Nano-Drug Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Johnson & Johnson Nano-Drug Product Portfolio
6.10.5 Johnson & Johnson Recent Developments/Updates
6.11 Celgene
6.11.1 Celgene Corporation Information
6.11.2 Celgene Nano-Drug Description and Business Overview
6.11.3 Celgene Nano-Drug Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Celgene Nano-Drug Product Portfolio
6.11.5 Celgene Recent Developments/Updates
6.12 Novavax
6.12.1 Novavax Corporation Information
6.12.2 Novavax Nano-Drug Description and Business Overview
6.12.3 Novavax Nano-Drug Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Novavax Nano-Drug Product Portfolio
6.12.5 Novavax Recent Developments/Updates
6.13 Stryker
6.13.1 Stryker Corporation Information
6.13.2 Stryker Nano-Drug Description and Business Overview
6.13.3 Stryker Nano-Drug Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Stryker Nano-Drug Product Portfolio
6.13.5 Stryker Recent Developments/Updates
6.14 Gilead Sciences
6.14.1 Gilead Sciences Corporation Information
6.14.2 Gilead Sciences Nano-Drug Description and Business Overview
6.14.3 Gilead Sciences Nano-Drug Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Gilead Sciences Nano-Drug Product Portfolio
6.14.5 Gilead Sciences Recent Developments/Updates
6.15 OSI Pharmaceuticals
6.15.1 OSI Pharmaceuticals Corporation Information
6.15.2 OSI Pharmaceuticals Nano-Drug Description and Business Overview
6.15.3 OSI Pharmaceuticals Nano-Drug Sales, Revenue and Gross Margin (2019-2024)
6.15.4 OSI Pharmaceuticals Nano-Drug Product Portfolio
6.15.5 OSI Pharmaceuticals Recent Developments/Updates
6.16 Kadmon Pharmaceuticals
6.16.1 Kadmon Pharmaceuticals Corporation Information
6.16.2 Kadmon Pharmaceuticals Nano-Drug Description and Business Overview
6.16.3 Kadmon Pharmaceuticals Nano-Drug Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Kadmon Pharmaceuticals Nano-Drug Product Portfolio
6.16.5 Kadmon Pharmaceuticals Recent Developments/Updates
6.17 Samyang Biopharm
6.17.1 Samyang Biopharm Corporation Information
6.17.2 Samyang Biopharm Nano-Drug Description and Business Overview
6.17.3 Samyang Biopharm Nano-Drug Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Samyang Biopharm Nano-Drug Product Portfolio
6.17.5 Samyang Biopharm Recent Developments/Updates
6.18 Mitsubishi Pharma
6.18.1 Mitsubishi Pharma Corporation Information
6.18.2 Mitsubishi Pharma Nano-Drug Description and Business Overview
6.18.3 Mitsubishi Pharma Nano-Drug Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Mitsubishi Pharma Nano-Drug Product Portfolio
6.18.5 Mitsubishi Pharma Recent Developments/Updates
6.19 Kaken Pharmaceutical
6.19.1 Kaken Pharmaceutical Corporation Information
6.19.2 Kaken Pharmaceutical Nano-Drug Description and Business Overview
6.19.3 Kaken Pharmaceutical Nano-Drug Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Kaken Pharmaceutical Nano-Drug Product Portfolio
6.19.5 Kaken Pharmaceutical Recent Developments/Updates
6.20 Selecta Biosciences
6.20.1 Selecta Biosciences Corporation Information
6.20.2 Selecta Biosciences Nano-Drug Description and Business Overview
6.20.3 Selecta Biosciences Nano-Drug Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Selecta Biosciences Nano-Drug Product Portfolio
6.20.5 Selecta Biosciences Recent Developments/Updates
6.21 Par Pharmaceutical
6.21.1 Par Pharmaceutical Corporation Information
6.21.2 Par Pharmaceutical Nano-Drug Description and Business Overview
6.21.3 Par Pharmaceutical Nano-Drug Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Par Pharmaceutical Nano-Drug Product Portfolio
6.21.5 Par Pharmaceutical Recent Developments/Updates
6.22 Cerulean Pharma
6.22.1 Cerulean Pharma Corporation Information
6.22.2 Cerulean Pharma Nano-Drug Description and Business Overview
6.22.3 Cerulean Pharma Nano-Drug Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Cerulean Pharma Nano-Drug Product Portfolio
6.22.5 Cerulean Pharma Recent Developments/Updates
6.23 Navidea Biopharmaceuticals
6.23.1 Navidea Biopharmaceuticals Corporation Information
6.23.2 Navidea Biopharmaceuticals Nano-Drug Description and Business Overview
6.23.3 Navidea Biopharmaceuticals Nano-Drug Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Navidea Biopharmaceuticals Nano-Drug Product Portfolio
6.23.5 Navidea Biopharmaceuticals Recent Developments/Updates
6.24 Lummy
6.24.1 Lummy Corporation Information
6.24.2 Lummy Nano-Drug Description and Business Overview
6.24.3 Lummy Nano-Drug Sales, Revenue and Gross Margin (2019-2024)
6.24.4 Lummy Nano-Drug Product Portfolio
6.24.5 Lummy Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nano-Drug Industry Chain Analysis
7.2 Nano-Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nano-Drug Production Mode & Process
7.4 Nano-Drug Sales and Marketing
7.4.1 Nano-Drug Sales Channels
7.4.2 Nano-Drug Distributors
7.5 Nano-Drug Customers
8 Nano-Drug Market Dynamics
8.1 Nano-Drug Industry Trends
8.2 Nano-Drug Market Drivers
8.3 Nano-Drug Market Challenges
8.4 Nano-Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock